Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2

Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2

The mutants resulted from the ongoing SARS-CoV-2 epidemic have showed resistance to antibody neutralization and vaccine-induced immune response. The present study isolated and identified two novel SARS-CoV-2 neutralizing antibodies (nAbs) from convalescent COVID-19 patients. These two nAbs (XG81 and...

Full description

Bibliographic Details
Main Authors: Jiajia Xie, Chengchao Ding, Jun He, Yuqing Zhang, Shuangshuang Ni, Xiangyu Zhang, Qingqing Chen, Jing Wang, Lina Huang, Hongliang He, Wenting Li, Huan Ma, Tengchuan Jin, Siping Zhang, Yong Gao
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Immunology
Subjects:
SARS-CoV-2
neutralizing antibody
recombined antibody
mutation resistance
RBD binding affinity
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.715464/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.715464/full

Similar Items